Results 151 to 160 of about 226,558 (238)

Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology

, 2005
Summary Objective: To compare severity of negative mood and physical symptoms between women with different progesterone, allopregnanolone, and pregnanolone plasma concentrations during sequential Hormone Replacement Therapy (HRT) with vaginal ...
Marie Bixo, Torbjörn Bäckström, Inger Sundström-Poromaa, Agneta Andersson, Sigrid Nyberg, Lotta Andréen   +5 more
core  

Is the use of vaginal progesterone a factor in pregnant women diagnosed with gestational diabetes mellitus? [PDF]

Rev Assoc Med Bras (1992)
Kanbak AR, Öztekin DC.
europepmc   +1 more source

Vaginal Progesterone Effects on Ultrasound Indices, Fetal Outcomes, and Preeclampsia in High-risk Pregnancy : Vaginal Progesterone in High-risk Pregnancy: Ultrasound Indices and Outcomes. [PDF]

Galen Med J
Darzi S, Arabian S, Motamedi Kia P, Rahimi Pordanjani S, Saffarieh E.   +4 more
europepmc   +1 more source

A randomised control trial on oral dydrogesterone versus micronized vaginal progesterone pessary for luteal phase support in in vitro fertilization cycles. [PDF]

J Med Life, 2023
Ikechebelu JI, Dim CC, Eleje GU, Joe-Ikechebelu N, Okpala BC, Okam PC.   +5 more
europepmc   +1 more source

Vaginal progesterone and the risk of preterm birth in patients with short cervix beyond 24 weeks. [PDF]

Int J Gynaecol Obstet
Dominsky O, Anteby M, Berkovitz-Shperling R, Gilboa I, Simon N, Kalish DW, Yogev Y, Hiersch L, Rimon E.   +8 more
europepmc   +1 more source

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT-FET cycles. [PDF]

Reprod Med Biol, 2023
Toriumi R, Horikawa M, Sato C, Shimamura N, Ishii R, Terashima M, Hamada M, Tachibana N, Taketani Y.   +8 more
europepmc   +1 more source

Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen-Thawed Embryo Transfer With Hormone Replacement Therapy. [PDF]

Reprod Med Biol
Sekiguchi M, Ito A, Katagiri Y, Yoneyama M, Tsuchiya T, Furui M, Umemura N, Kobayashi H, Nakata M.   +8 more
europepmc   +1 more source

Use of oral estradiol plus vaginal progesterone in healthy postmenopausal women. [PDF]

Maturitas, 2021
Sriprasert I, Mert M, Mack WJ, Hodis HN, Shoupe D.   +4 more
europepmc   +1 more source

Dydrogesterone versus micronized vaginal progesterone for luteal phase support in artificial cycle frozen embryo transfer (REMODEL): a pilot prospective randomized controlled trial. [PDF]

Front Endocrinol (Lausanne)
Roelens C, Mackens S, Drakopoulos P, Van Landuyt L, De Vos M, Tournaye H, Blockeel C.   +6 more
europepmc   +1 more source

The effectiveness of vaginal progesterone in reducing preterm birth in high-risk patients diagnosed with short cervical length after 24 weeks: A retrospective cohort study. [PDF]

Front Med (Lausanne), 2023
Luxenbourg D, Porat S, Romero R, Raif Nesher D, Haj Yahya R, Sompolinsky Y, Hochler H, Ezra Y, Kabiri D.   +8 more
europepmc   +1 more source